We would like to welcome Doctor John Parisot to Phenomics Australia’s team. John brings a wealth of experience in therapeutic R&D, project management, and functional genomics to our team. His insights will help consolidate strategic partnerships to further our vision of better health through the discovery of gene function.
John Parisot has over 20 years’ experience in therapeutic R&D for pharmaceutical companies, biotechs, and world-leading medical research institutes. He is an experienced project manager deft at managing stakeholder relationships in key collaborations and who has succeeded in projects running from target validation via in vitro or in vivo models, to preclinical drug discovery and assay development for high-throughput screening, to lead identification and optimization to develop drugs suitable for human clinical trials. He has a comprehensive understanding of the path to market for new drug entities. His involvement has been within drug development within multiple therapeutic disease areas encompassing cancer, respiratory, inflammatory, tropical diseases, and more recently, immunotherapeutic targets. He has a deep understanding of the pre-clinical to regulatory pathways to develop new therapies for approval by the TGA & FDA and will be managing the functional genomics portfolios of Bioplatforms/Phenomics Australia via a shared appointment.
“I am pleased to be able to join the Phenomics Australia team and play an important collaborative role contributing to the synergy between several health-related NCRIS members in their interactions with stakeholders and researchers”